A Clinical Trial to Evaluate Safety, Tolerance and Pharmacokinetics of JX11502MA Capsule in Patients With Schizophrenia.

NCT06356389 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

60

Enrollment

INDUSTRY

Sponsor class

Conditions

Schizophrenia

Interventions

DRUG: JX11502MA
DRUG: Placebo

Sponsor

Zhejiang Jingxin Pharmaceutical Co., Ltd.

Collaborators

[object Object]